Performance indicators in breast cancer screening in the European Union: A comparison across countries of screen positivity and detection rates
Paola Armaroli(Piedmont Reference Center for Epidemiology and Cancer Prevention), Nereo Segnan(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), André Lopes Carvalho(Hospital de Câncer de Barretos), Joakim Dillner(Karolinska University Hospital), Stefan Lönnberg(Finnish Cancer Registry), Antonio Ponti(Piedmont Reference Center for Epidemiology and Cancer Prevention), Katja Jarm(Institute of Oncology Ljubljana), Ahti Anttila(Finnish Cancer Registry), Isabelle Soerjomataram(Centre international de recherche sur le cancer), Carlo Senore(CTO Hospital), Rengaswamy Sankaranarayanan(Centre International de Recherche sur le Cancer), Emilia Riggi(Piedmont Reference Center for Epidemiology and Cancer Prevention), Miriam Elfström(Karolinska University Hospital), Livia Giordano(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Gugliemo Ronco(Piedmont Reference Center for Epidemiology and Cancer Prevention), Partha Basu(Centre international de recherche sur le cancer), Mariano Tomatis(Piedmont Reference Center for Epidemiology and Cancer Prevention), Diama Bhadra Vale(Universidade Estadual de Campinas (UNICAMP))
Cited by 11
Related Papers
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
|CA A Cancer Journal for Clinicians|2021|112.4k
Cancer of the cervix uteri
|International Journal of Gynecology & Obstetrics|2018|1.1k
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
|The Lancet Oncology|2019|1k
Revised FIGO staging for carcinoma of the cervix uteri
|International Journal of Gynecology & Obstetrics|2019|1k
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
|The Lancet Oncology|2014|994